| Autism-like phenotype and risk gene mRNA deadenylation by CPEB4 mis-splicing A Parras, H Anta, M Santos-Galindo, V Swarup, A Elorza, ... Nature 560 (7719), 441-446, 2018 | 127 | 2018 |
| Impaired development of neocortical circuits contributes to the neurological alterations in DYRK1A haploinsufficiency syndrome J Arranz, E Balducci, K Arató, G Sánchez-Elexpuru, S Najas, A Parras, ... Neurobiology of disease 127, 210-222, 2019 | 41 | 2019 |
| Surface Display of Designer Protein Scaffolds on Genome-Reduced Strains of Pseudomonas putida P Dvorak, EA Bayer, V de Lorenzo ACS Synthetic Biology 9 (10), 2749-2764, 2020 | 22 | 2020 |
| High concordance between hippocampal transcriptome of the mouse intra‐amygdala kainic acid model and human temporal lobe epilepsy G Conte, A Parras, M Alves, I Ollà, L De Diego‐Garcia, E Beamer, ... Epilepsia 61 (12), 2795-2810, 2020 | 18 | 2020 |
| Polyadenylation of mRNA as a novel regulatory mechanism of gene expression in temporal lobe epilepsy A Parras, L de Diego-Garcia, M Alves, E Beamer, G Conte, ... Brain 143 (7), 2139-2153, 2020 | 15 | 2020 |
| CPEB alteration and aberrant transcriptome-polyadenylation lead to a treatable SLC19A3 deficiency in Huntington’s disease S Picó, A Parras, M Santos-Galindo, J Pose-Utrilla, M Castro, E Fraga, ... Science Translational Medicine 13 (613), eabe7104, 2021 | 14 | 2021 |
| The P2X7 receptor contributes to seizures and inflammation‐driven long‐lasting brain hyperexcitability following hypoxia in neonatal mice J Smith, A Menéndez Méndez, M Alves, A Parras, G Conte, ... British Journal of Pharmacology 180 (13), 1710-1729, 2023 | 11 | 2023 |
| In vivo reprogramming leads to premature death linked to hepatic and intestinal failure A Parras, A Vílchez-Acosta, G Desdín-Micó, S Picó, C Mrabti, ... Nature Aging 3 (12), 1509-1520, 2023 | 9 | 2023 |
| In vivo reprogramming leads to premature death due to hepatic and intestinal failure A Parras, A Vílchez-Acosta, G Desdín-Micó, C Mrabti, C Rechsteiner, ... bioRxiv, 2022.05. 27.493700, 2022 | 4 | 2022 |
| Pathogenic mis-splicing of CPEB4 in schizophrenia I Ollà, AF Pardiñas, A Parras, IH Hernández, M Santos-Galindo, S Picó, ... Biological Psychiatry 94 (4), 341-351, 2023 | 3 | 2023 |
| ERCC1 mice, unlike other premature aging models, display accelerated epigenetic age K Perez, A Parras, C Rechsteiner, A Haghani, R Brooke, C Mrabti, ... bioRxiv, 2022.12. 28.522011, 2022 | 3 | 2022 |
| DNA repair‐deficient premature aging models display accelerated epigenetic age K Perez, A Parras, S Picó, C Rechsteiner, A Haghani, R Brooke, C Mrabti, ... Aging Cell, e14058, 2024 | 1 | 2024 |
| Initiation phase cellular reprogramming ameliorates DNA damage in the ERCC1 mouse model of premature aging PT Paine, C Rechsteiner, F Morandini, G Desdín-Micó, C Mrabti, A Parras, ... Frontiers in Aging 4, 1323194, 2024 | | 2024 |
| Comparative analysis of mouse strains for in vivo reprogramming S Pico, A Vilchez Acosta, JA de Sousa, MC Maza, A Parras, ... bioRxiv, 2024.03. 08.584074, 2024 | | 2024 |
| CPEB4–CLOCK crosstalk during temporal lobe epilepsy L de Diego‐Garcia, GP Brennan, T Auer, A Menendez‐Mendez, A Parras, ... Epilepsia 64 (10), 2827-2840, 2023 | | 2023 |
| I03 CPEB alteration and aberrant transcriptome-polyadenylation unveil a treatable vitamin B1 deficiency in huntington’s disease S Pico, A Parras, M Santos-Galindo, J Pose-Utrilla, M Castro, E Fraga, ... Journal of Neurology, Neurosurgery & Psychiatry 92 (Suppl 1), A49-A49, 2021 | | 2021 |
| Combined use of biotin and thiamine in the treatment of Huntington's disease JJ Lucas, S Picó, A Parras, M Santos-Galindo | | 2021 |
| Uso combinado de biotina y tiamina en el tratamiento de la enfermedad de Huntington JJ Lucas, S Picó, A Parras, M Santos-Galindo | | 2021 |
| Large-scale changes to mRNA polyadenylation in temporal lobe epilepsy A Parras, L de Diego-Garcia, M Alves, E Beamer, G Conte, J Morgan, ... bioRxiv, 725325, 2019 | | 2019 |
| Role of CPEB4 in Huntington´ s Disease and in Autism Spectrum Disorder A Parras Rodríguez | | 2017 |
